340B ACCESS Act
The 340B ACCESS Act amends the 340B Drug Pricing Program to strengthen oversight and ensure discounts reach vulnerable populations. It establishes new patient affordability requirements that limit out-of-pocket costs for eligible patients (e.g., $0 for those below the Federal poverty line, up to $35 for those between poverty line and 200% of poverty). The bill adds requirements for hospital child sites, contract pharmacies, and covered entities to prevent duplicate discounts, improve transparency, and creates a claims data clearinghouse to monitor program compliance. It imposes civil penalties for noncompliance, including fines up to $13,946 per violation for contract pharmacies that violate program requirements.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2024
Committee Review
Floor Vote
President
Introduced May 28, 2024
Last action Dec 17, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
3
Dec 17, 2024
Committee
Referred to the Subcommittee on Health.
lower
May 31, 2024
Committee
Referred to the Subcommittee on Health.
lower
May 28, 2024
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
May 28, 2024
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Larry Bucshon
RRepublican
Co
Diana Harshbarger
RRepublican
Co
Earl L. "Buddy" Carter
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8574
Scope: US
Hi! I can help you understand HR 8574. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline